Ian D. Dang

Array ( [id] => 6062188 [patent_doc_number] => 20110200607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Binding Proteins Specific for Insulin-Like Growth Factors and uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/078480 [patent_app_country] => US [patent_app_date] => 2011-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 29854 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20110200607.pdf [firstpage_image] =>[orig_patent_app_number] => 13078480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936029 [patent_doc_number] => 20110212127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine' [patent_app_type] => utility [patent_app_number] => 13/076742 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31555 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212127.pdf [firstpage_image] =>[orig_patent_app_number] => 13076742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6150229 [patent_doc_number] => 20110021744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'PROCESS FOR PREPARING PURIFIED DRUG CONJUGATES' [patent_app_type] => utility [patent_app_number] => 12/901039 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14212 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021744.pdf [firstpage_image] =>[orig_patent_app_number] => 12901039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039375 [patent_doc_number] => 20110092424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'PRODUCTION OF GLUCAGON LIKE PEPTIDE 2 AND ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/895517 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6028 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092424.pdf [firstpage_image] =>[orig_patent_app_number] => 12895517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148747 [patent_doc_number] => 20110020342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'IGF-1 FUSION POLYPEPTIDES AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/894278 [patent_app_country] => US [patent_app_date] => 2010-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9994 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020342.pdf [firstpage_image] =>[orig_patent_app_number] => 12894278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024265 [patent_doc_number] => 20110052591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Variants of Thyroid Stimulating Hormone Beta' [patent_app_type] => utility [patent_app_number] => 12/871716 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 36449 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052591.pdf [firstpage_image] =>[orig_patent_app_number] => 12871716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6189783 [patent_doc_number] => 20110172146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'GROWTH HORMONE POLYPEPTIDES AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/848984 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 73194 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172146.pdf [firstpage_image] =>[orig_patent_app_number] => 12848984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8995003 [patent_doc_number] => 08518887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-27 [patent_title] => 'Method of treating cancer with DLL4 antagonist and chemotherapeutic agent' [patent_app_type] => utility [patent_app_number] => 12/823680 [patent_app_country] => US [patent_app_date] => 2010-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15014 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12823680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6486838 [patent_doc_number] => 20100285529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'FELINE GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/819964 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48094 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20100285529.pdf [firstpage_image] =>[orig_patent_app_number] => 12819964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173570 [patent_doc_number] => 20120108512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'STABLE PHARMACEUTICAL COMPOSITIONS OF PEPTIDE DERIVATIZED USING AN OXIME LINKER' [patent_app_type] => utility [patent_app_number] => 13/318865 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17332 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108512.pdf [firstpage_image] =>[orig_patent_app_number] => 13318865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9250406 [patent_doc_number] => 08614185 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'Fusion proteins of alpha-MSH derivatives and Fc' [patent_app_type] => utility [patent_app_number] => 12/768093 [patent_app_country] => US [patent_app_date] => 2010-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7959 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12768093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6327998 [patent_doc_number] => 20100197722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'Treatment for basal cell carcinoma' [patent_app_type] => utility [patent_app_number] => 12/798356 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4846 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197722.pdf [firstpage_image] =>[orig_patent_app_number] => 12798356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8220781 [patent_doc_number] => 20120134985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'METHODS FOR MODULATING METABOLIC AND CIRCADIAN RHYTHMS' [patent_app_type] => utility [patent_app_number] => 13/257758 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14250 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7808001 [patent_doc_number] => 20120058955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'USE OF DECORINE FOR INCREASING MUSCLE MASS' [patent_app_type] => utility [patent_app_number] => 13/257127 [patent_app_country] => US [patent_app_date] => 2010-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3983 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058955.pdf [firstpage_image] =>[orig_patent_app_number] => 13257127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791562 [patent_doc_number] => 20120053118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'METHODS FOR AFFECTING BODY COMPOSITION USING AMYLIN AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/256779 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 44079 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053118.pdf [firstpage_image] =>[orig_patent_app_number] => 13256779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6432809 [patent_doc_number] => 20100278736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'FLT4 (VEGFR-3) as a Target for Tumor Imaging and Anti-Tumor Therapy' [patent_app_type] => utility [patent_app_number] => 12/707423 [patent_app_country] => US [patent_app_date] => 2010-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29031 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0278/20100278736.pdf [firstpage_image] =>[orig_patent_app_number] => 12707423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7742097 [patent_doc_number] => 20120020889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin' [patent_app_type] => utility [patent_app_number] => 13/145059 [patent_app_country] => US [patent_app_date] => 2010-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18090 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20120020889.pdf [firstpage_image] =>[orig_patent_app_number] => 13145059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972493 [patent_doc_number] => 20110152186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES' [patent_app_type] => utility [patent_app_number] => 12/643261 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 31738 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152186.pdf [firstpage_image] =>[orig_patent_app_number] => 12643261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375786 [patent_doc_number] => 08680051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Method of ameliorating symptoms of type 1-diabetes using GABA related compounds and GLP-1/exendin-4 compounds' [patent_app_type] => utility [patent_app_number] => 12/643008 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 11 [patent_no_of_words] => 21862 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12643008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386160 [patent_doc_number] => 08263552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Glucagon-like-peptide-2 (GLP-2) analogues' [patent_app_type] => utility [patent_app_number] => 12/643233 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 31893 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12643233 [rel_patent_id] =>[rel_patent_doc_number] =>)